首页> 外国专利> New pharmaceutical compositions intended for the application of the eye, which contains a derivative androstenique and their method of preparation.

New pharmaceutical compositions intended for the application of the eye, which contains a derivative androstenique and their method of preparation.

机译:用于眼睛应用的新药物组合物,其包含衍生物雄烯二酸及其制备方法。

摘要

The invention relates to the field of formulation pharmaceutics. It relates to novel pharmaceutical compositions intended for ocular application, which contain as active principle at least one androstene derivative of general formula I IMAGE in which R1 represents hydrogen, a lower alkyl radical, a methoxyalkyl or an acyl derived from an organic carboxylic or carbonic acid and R and R2 are defined as in the description in combination or mixed with a pharmaceutical, non-toxic, inert vehicle or excipient. The compositions according to the invention are a medicament for the treatment of intraocular hypertension and glaucoma.
机译:本发明涉及制剂药物领域。本发明涉及用于眼科应用的新型药物组合物,其包含至少一种通式I 的雄烯衍生物作为活性成分,其中R1代表氢,低级烷基,甲氧基烷基或衍生自有机羧酸或烷基的酰基。碳酸和R 1和R 2如说明书中所定义,与药学上,无毒,惰性载体或赋形剂组合或混合。根据本发明的组合物是用于治疗眼内高压和青光眼的药物。

著录项

  • 公开/公告号FR2679139B1

    专利类型

  • 公开/公告日1995-03-17

    原文格式PDF

  • 申请/专利权人 THERAMEX SA LABORATOIRE;

    申请/专利号FR19910009017

  • 发明设计人 GERARD SCHWADROHN;

    申请日1991-07-17

  • 分类号A61K31/565;

  • 国家 FR

  • 入库时间 2022-08-22 04:07:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号